DGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quest Diagnostics Inc (DGX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and hedge fund buying activity indicate a solid growth trajectory. While there are no immediate technical or AI trading signals, the overall fundamentals and market sentiment support a long-term investment.
The technical indicators are bullish. The MACD histogram is positive and expanding, the RSI is in the neutral zone at 74.055, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near resistance levels (R1: 211.541), with key support at 202.174.
Hedge fund buying has increased significantly (up 1536.08% last quarter).
Analysts have raised price targets across the board, with the highest target at $
Strong Q4 financial performance with revenue up 7.06%, net income up 11.36%, and EPS up 15.26% YoY.
Appointment of a new Chief Strategy and M&A Officer to drive growth and acquisitions.
Gross margin dropped slightly (-1.45% YoY) in Q4
Stock trend analysis suggests a potential short-term decline (-6.7% in the next week).
In Q4 2025, Quest Diagnostics reported revenue of $2.806 billion (up 7.06% YoY), net income of $245 million (up 11.36% YoY), and EPS of 2.19 (up 15.26% YoY). However, gross margin dropped slightly to 31.25% (-1.45% YoY).
Analysts are generally positive on DGX, with multiple firms raising price targets recently. The highest target is $235 (Mizuho), and the lowest is $210 (UBS). Ratings range from Neutral to Outperform, with some firms highlighting strong organic growth and margin expansion in FY26.
